Heregulin ameliorates the dystrophic phenotype in mdx mice.

Heregulin ameliorates the dystrophic phenotype in mdx mice.

Duchenne's muscular dystrophy (DMD) is a fatal neuromuscular disease caused by absence of dystrophin. Utrophin is a chromosome 6-encoded dystrophin-related protein (DRP), sharing functional motifs with dystrophin. Utrophin's ability to compensate for dystrophin during development and when...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Krag, T, Bogdanovich, S, Jensen, C, Fischer, M, Hansen-Schwartz, J, Javazon, E, Flake, A, Edvinsson, L, Khurana, T
Natura:	Journal article
Lingua:	English
Pubblicazione:	2004

Documenti analoghi

l-arginine improves dystrophic phenotype in mdx mice
di: Vincent Voisin, et al.
Pubblicazione: (2005-10-01)

Heregulin-induced epigenetic regulation of the utrophin-A promoter.
di: Basu, U, et al.
Pubblicazione: (2007)

Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
di: Rafael Dias Mâncio, et al.
Pubblicazione: (2017-01-01)

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice
di: D. Feder, et al.
Pubblicazione: (2014-11-01)

Proteome Profiling of the Dystrophic <i>mdx</i> Mice Diaphragm
di: Olga Mucha, et al.
Pubblicazione: (2023-11-01)

Choline administration attenuates aspects of the dystrophic pathology in mdx mice
di: Francesca M. Alves, et al.
Pubblicazione: (2019-04-01)

Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice.
di: David I Stapleton, et al.
Pubblicazione: (2014-01-01)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
di: Sang, E, et al.
Pubblicazione: (2000)

Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.
di: Yusuke Echigoya, et al.
Pubblicazione: (2013-01-01)

T-cell-dependent fibrosis in the mdx dystrophic mouse.
di: Morrison, J, et al.
Pubblicazione: (2000)

Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype mdx Rodent
di: Arkady Uryash, et al.
Pubblicazione: (2021-05-01)

Decrease in prosaposin in the Dystrophic mdx mouse brain.
di: Hui-Ling Gao, et al.
Pubblicazione: (2013-01-01)

Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
di: Bruce E Markham, et al.
Pubblicazione: (2015-01-01)

A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in <i>mdx</i> Mice
di: Francesca Gasparella, et al.
Pubblicazione: (2024-05-01)

MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice
di: Laura ePelosi, et al.
Pubblicazione: (2015-05-01)

Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice.
di: Luca Madaro, et al.
Pubblicazione: (2019-10-01)

A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy
di: Chady H. Hakim, et al.
Pubblicazione: (2017-09-01)

Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery.
di: Aoki, Y, et al.
Pubblicazione: (2012)

Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice
di: Emily Freeman, et al.
Pubblicazione: (2024-04-01)

Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice
di: Hannah G. Radley, et al.
Pubblicazione: (2006-08-01)

Increased susceptibility of the dystrophic mdx mouse heart to ischemic and hypoxic injuries
di: Zhang, W, et al.
Pubblicazione: (2005)

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
di: William J. Valentine, et al.
Pubblicazione: (2022-01-01)

Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction.
di: Jessica R Terrill, et al.
Pubblicazione: (2017-01-01)

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
di: Lu, Q, et al.
Pubblicazione: (2003)

Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice
di: Chiara Mozzetta, et al.
Pubblicazione: (2013-03-01)

The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice.
di: Milind R Chaudhari, et al.
Pubblicazione: (2016-01-01)

Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits.
di: Christopher R Heier, et al.
Pubblicazione: (2014-01-01)

Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice
di: Mingxing Wang, et al.
Pubblicazione: (2016-01-01)

Subproteomic profiling of sarcolemma from dystrophic mdx-4cv skeletal muscle
di: Sandra Murphy, et al.
Pubblicazione: (2018-04-01)

Use of antisense-mediated exon skipping to generate dystrophin in muscles of the mdx dystrophic mouse
di: Lu, Q, et al.
Pubblicazione: (2004)

Tempol treatment shows phenotype improvement in mdx mice.
di: Túlio de Almeida Hermes, et al.
Pubblicazione: (2019-01-01)

RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice
di: Jae‐Sung You, et al.
Pubblicazione: (2023-08-01)

Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle
di: Annamaria De Luca, et al.
Pubblicazione: (2008-11-01)

Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx mice.
di: Yeranuhi Hovhannisyan, et al.
Pubblicazione: (2019-01-01)

Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.
di: Yuko Shimizu-Motohashi, et al.
Pubblicazione: (2015-01-01)

Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study.
di: Zhang, W, et al.
Pubblicazione: (2008)

Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology
di: Daniel P. Reay, et al.
Pubblicazione: (2011-09-01)

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice
di: Jessica R. Terrill, et al.
Pubblicazione: (2024-06-01)

Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice.
di: Francisco Altamirano, et al.
Pubblicazione: (2013-01-01)

Lack of dystrophin leads to the selective loss of superior cervical ganglion neurons projecting to muscular targets in genetically dystrophic mdx mice
di: M. Egle De Stefano, et al.
Pubblicazione: (2005-12-01)